Understanding What the CLL 10-Year Progression-Free Survival of Ibrutinib Means
Experts explained the meaning of the CLL 10-year progression-free survival of Ibrutinib during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Are CLL Patients At-Risk for AML or CML?
Experts responded to a viewer question about the risk of AML and CML during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
What’s the Outlook for Future CLL Care?
Dr. William Wierda and Dr. Patrick Reville share their hope for the future of CLL care.
CLL Research Updates From ASH 2023
Experts discussed the latest updates from the 2023 American Society of Hematology (ASH) meeting.
CLL Global Virtual Town Hall: February 7, 2024
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Let’s Talk CLL! Questions & Answers
Q&A from the Let’s Talk CLL Town Hall.
Let’s Talk CLL! Finding a CLL Specialist
Finding a CLL Specialist from the Let’s Talk CLL Town Hall.
Let’s Talk CLL! Strategies for Coping & Living Well with CLL
Strategies for Coping & Living Well with CLL from the Let’s Talk CLL! Town Hall.
Let’s Talk CLL! Optimized Care & Limiting Side Effects
Optimized Care & Limiting Side Effects from the Let’s Talk CLL! Town Hall.
Let’s Talk CLL! Vaccines & CLL
Vaccines & CLL from the Let’s Talk CLL! Town Hall.